Shots: The approval is based on P-III trial Fixed Combination Drug Product LDL-C Lowering program, involves assessing of Nexlizet vs PBO when added on to maximally tolerated statins The study […]readmore
Tags : Tablet
Shots: The approval is based on P-III global pivotal Phase 3 LDL-C lowering program assessing NEXLETOL vs PBO in 3000+ patients corrected LDL-C lowering when used with moderate or high […]readmore